Takeaway: DRI is one of our least favorite names in casual dining as industry- and company-specific factors dampen our view of the stock

Keith shorted DRI this year as his quantitative analysis lined up with one of the most important calls we made in 2012.


Fundamental View


Darden remains one of our top ideas on the short side.  Company- and industry-specific issues that we highlighted in our July black book, “DRI: THE UNTHINKABLE SHORT CASE”, are coming to the fore. 

  • Industry trends are slowing (see Knapp Track chart, below)
  • Darden likely needs a recovery in industry trends to achieve its targets of 1-2% SRS growth at Olive Garden, Red Lobster and LongHorn (again, see Knapp Track chart, below)
  • Darden’s two most important chains, Olive Garden and Red Lobstser, continue to underperform versus the industry
  • With jobless claims and difficult comparisons versus a year ago (weather) over the next few months, we are not expecting much good news on Darden’s top-line
  • The company’s CMO leaving is a negative, particularly seen as the management team did not announce a replacement.  Marketing is a key factor in driving traffic in casual dining and this news only adds to our bearish view of Darden’s sales outlook
  • While earnings expectations continue to decline, we believe the Street’s expectations remain too bullish on this name
  • The company's growth, dividend payments, and share repurchases are becoming more and more difficult to sustain under the company's current path.

IDEA ALERT: SHORTING DRI - olive garden knapp track ttm



Quantitative Setup



Howard Penney

Managing Director


Rory Green



GOLD: A Deep Dive on What’s Next with a Top Commodities Strategist

“If you saved in gold over the past 20 to 25 years rather than any currency anywhere in the world, gold has outperformed all these currencies,” says Stefan Wieler, Vice President of Goldmoney in this edition of Real Conversations.

read more

Exact Sciences Up +24% This Week... What's Next? | $EXAS

We remain long Exact Sciences in the Hedgeye Healthcare Position Monitor.

read more

Inside the Atlanta Fed's Flawed GDP Tracker

"The Atlanta Fed’s GDPNowcast model, while useful at amalgamating investor consensus on one singular GDP estimate for any given quarter, is certainly not the end-all-be-all of forecasting U.S. GDP," writes Hedgeye Senior Macro analyst Darius Dale.

read more

Cartoon of the Day: Acrophobia

"Most people who are making a ton of money right now are focused on growth companies seeing accelerations," Hedgeye CEO Keith McCullough wrote in today's Early Look. "That’s what happens in Quad 1."

read more

People's Bank of China Spins China’s Bad-Loan Data

PBoC Deputy Governor Yi says China's non-performing loan problem has “pretty much stabilized." "Yi is spinning. China’s bad-debt problem remains serious," write Benn Steil and Emma Smith, Council on Foreign Relations.

read more

UnderArmour: 'I Am Much More Bearish Than I Was 3 Hours Ago'

“The consumer has a short memory.” Yes, Plank actually said this," writes Hedgeye Retail analyst Brian McGough. "Last time I heard such arrogance was Ron Johnson."

read more

Buffalo Wild Wings: Complacency & Lack of Leadership (by Howard Penney)

"Buffalo Wild Wings has been plagued by complacency and a continued lack of adequate leadership," writes Hedgeye Restaurants analyst Howard Penney.

read more

Todd Jordan on Las Vegas Sands Earnings

"The quarter actually beat lowered expectations. Overall, the mass segment performed well although base mass lagging is a concern," writes Hedgeye Gaming, Lodging & Leisure analyst Todd Jordan on Las Vegas Sands.

read more

An Update on Defense Spending by Lt. Gen Emo Gardner

"Congress' FY17 omnibus appropriation will fully fund the Pentagon's original budget request plus $15B of its $30B supplemental request," writes Hedgeye Potomac Defense Policy analyst Lt. Gen Emerson "Emo" Gardner USMC Ret.

read more

Got Process? Zero Hedge Sells Fear, Not Truth

Fear sells. Always has. Look no further than Zero Hedge.

read more

REPLAY: Review of $EXAS Earnings Call (A Hedgeye Best Idea Long)

Our Healthcare Team made a monster call to be long EXAS - hear their updated thoughts.

read more

Capital Brief: 5 Things to Watch Right Now In Washington

Here's a quick look at some key issues investors should keep an eye on from Hedgeye's JT Taylor and our team of Washington Policy analysts in D.C.

read more